Expenditure for oncology drugs in Italy 2018, by category

This statistic shows the total expenditure for oncology drugs in Italy in 2018, broken down by category. According to data, the spending on monoclonal antibodies amounted to approximately 1.5 billion euros, whereas the expenditure for protein kinase inhibitors reached 923.6 million euros. Moreover, in 2018, 5.5 million euros were addressed to platinum-based drugs.

Expenditure for oncology drugs in Italy in 2018, by category

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

$39 $59 per month *
in the first 12 months
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2019

Region

Italy

Survey time period

2018

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Cancer in Italy"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.